Uramoto H - Search Results

1

The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.

Mizutani K, Guo X, Shioya A, Zhang J, Zheng J, Kurose N, Ishibashi H, Motono N, Uramoto H, Yamada S. Mizutani K, et al. Among authors: uramoto h. Int J Med Sci. 2019 Aug 14;16(9):1199-1206. doi: 10.7150/ijms.36071. eCollection 2019. Int J Med Sci. 2019. PMID: 31588184 Free PMC article.

2

A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFR.

Uramoto H, Uchiumi T, Izumi H, Kohno K, Oyama T, Sugio K, Yasumoto K. Uramoto H, et al. Anticancer Res. 2007 Jul-Aug;27(4B):2297-303. Anticancer Res. 2007. PMID: 17695517 Free article.

3

Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.

Onitsuka T, Uramoto H, Ono K, Takenoyama M, Hanagiri T, Oyama T, Izumi H, Kohno K, Yasumoto K. Onitsuka T, et al. Among authors: uramoto h. J Thorac Oncol. 2010 May;5(5):591-6. doi: 10.1097/JTO.0b013e3181d0a4db. J Thorac Oncol. 2010. PMID: 20150826 Free article.

4

Correlation between HLA alleles and EGFR mutation in Japanese patients with adenocarcinoma of the lung.

Uramoto H, So T, Nagata Y, Kuroda K, Shigematsu Y, Baba T, So T, Takenoyama M, Hanagiri T, Yasumoto K. Uramoto H, et al. J Thorac Oncol. 2010 Aug;5(8):1136-42. doi: 10.1097/JTO.0b013e3181e0b993. J Thorac Oncol. 2010. PMID: 20548248 Free article.

5

Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.

Nose N, Uramoto H, Iwata T, Hanagiri T, Yasumoto K. Nose N, et al. Among authors: uramoto h. Lung Cancer. 2011 Mar;71(3):350-5. doi: 10.1016/j.lungcan.2010.06.009. Epub 2010 Jul 8. Lung Cancer. 2011. PMID: 20615575

6

[Results of surgical resection for patients with pulmonary cryptococcosis].

Takenaka M, Hanagiri T, Oka S, Baba T, Yasuda M, Ono K, Uramoto H, So T, Takenoyama M, Yamada S, Yasumoto K. Takenaka M, et al. Among authors: uramoto h. J UOEH. 2010 Sep 1;32(3):237-43. doi: 10.7888/juoeh.32.237. J UOEH. 2010. PMID: 20857817 Japanese.

7

Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer.

Uramoto H, Yamada S, Hanagiri T. Uramoto H, et al. J Cardiothorac Surg. 2010 Oct 29;5:92. doi: 10.1186/1749-8090-5-92. J Cardiothorac Surg. 2010. PMID: 21034441 Free PMC article.

8

Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung.

Uramoto H, Yamada S, Hanagiri T. Uramoto H, et al. Anticancer Res. 2010 Nov;30(11):4717-20. Anticancer Res. 2010. PMID: 21115930

9

Detection of EGFR and K-ras mutations for diagnosis of multiple lung adenocarcinomas.

Iwata T, Sugio K, Uramoto H, Yamada S, Onitsuka T, Nose N, Ono K, Takenoyama M, Oyama T, Hanagiri T, Yasumoto K. Iwata T, et al. Among authors: uramoto h. Front Biosci (Landmark Ed). 2011 Jun 1;16(8):2961-9. doi: 10.2741/3891. Front Biosci (Landmark Ed). 2011. PMID: 21622214 Free article.

10

Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.

Hanagiri T, Takenaka M, Oka S, Shigematsu Y, Nagata Y, Shimokawa H, Uramoto H, Yamada S, Tanaka F. Hanagiri T, et al. Among authors: uramoto h. Eur Surg Res. 2011;47(4):211-7. doi: 10.1159/000333367. Epub 2011 Oct 21. Eur Surg Res. 2011. PMID: 22025080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters